The gvhd Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the gvhd Hub cannot guarantee the accuracy of translated content. The gvhd and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out moreCreate an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View gvhd content recommended for you
Featured:
The GvHD Hub are proud to present expert interviews directly from the 61st American Society of Hematology (ASH) meeting in Orlando, US. This interview with Florent Malard, Saint-Antoine Hospital, Paris, FR, was based on the question: Is the composition of gut fungal microbiota a predictor of mortality after allogeneic transplantation?
Dr Malard discusses the results of a study, presented during the ASH meeting, which found patients undergoing transplant had a low fungal microbiota diversity at day 0. This lack of diversity did not have an impact on outcome, unlike the bacteria microbiota. However, a high presence of Candida albicans at day 0 was associated with lower overall survival and GvHD-free disease-free survival. He concludes that moving forward, it will be important to consider how we integrate this new data into improvements in patient outcome.
Is the composition of gut fungal microbiota a predictor of mortality after allo-transplantation?